N
Nia Therapeutics
Nia Therapeutics is developing neurostimulation therapies to treat memory impairment
About Nia Therapeutics
Nia Therapeutics is a medical device company that develops brain-computer interfaces to enhance human performance and well-being. The company is focused on creating the world's first brain stimulation therapy to treat memory loss resulting from traumatic brain injury.
Founded in 2018 by Michael Kahana and Dan Rizzuto, Nia Therapeutics is developing a precision neurostimulation therapy. This therapy is designed for the more than 27 million Americans living with memory loss. The company's proprietary neurotechnology platform is engineered to interpret brain signals and deliver targeted electrical stimulation to restore memory function. Nia Therapeutics aims to provide first-in-class therapeutic devices for patients with memory loss due to brain injury and degenerative diseases.
Source: Dealroom company dataNews
Open roles
Nia Therapeutics in the Boston ecosystem
The Nia Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Creative Destruction Lab
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Nia Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nia Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


